Increased treatment persistence and its determinants in women with osteoporosis with prior fracture compared to those without fracture
Explore this paper's citation graph
Summary
It was found that pain increased treatment persistence in women with osteoporosis and fracture, and fracture only decreased the risk of treatment discontinuation when the model was not adjusted for pain medications.
- Type
- article
- Published
- 2016-03-01
- Cited by
- 12
- References
- 37
- OpenAlex
- https://openalex.org/W1927359556
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:7544406
Keywords
Medicine, Discontinuation, Persistence (discontinuity), Osteoporosis, Proportional hazards model
References
- Compliance of osteoporotic patients with different treatment regimens.
- Early discontinuation of treatment for osteoporosis.
- Medication compliance: a healthcare problem.
- Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study
- Persistence with denosumab therapy among osteoporotic women in the Canadian patient-support program
- Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis
- The epidemiology of osteoporosis--Bone Evaluation Study (BEST): an analysis of routine health insurance data.
- Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis
- Bisphosphonates for osteoporosis--where do we go from here?
- Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey
- Determinants of adherence to osteoporosis treatment in clinical practice
- Two‐Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD
- The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosis
- The clinical consequences of vertebral compression fracture.
- Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography.
- Clinical profile of acute vertebral compression fractures in osteoporosis.
- GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates
- Compliance with treatment regimens in chronic asymptomatic diseases.
- Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
- Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases.
Cited by
- Age-related differences in persistence in women with breast cancer treated with tamoxifen or aromatase inhibitors in Germany.
- The use of proton pump inhibitors is positively associated with osteoporosis in postmenopausal women in Germany
- Gender- and age-related treatment compliance in patients with osteoporosis in Germany
- Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany—A retrospective analysis of real-world data
- Adherence to antiepileptic drugs in children and adolescents: A retrospective study in primary care settings in Germany.
- A dedicated Fracture Liaison Service telephone program and use of bone turnover markers for evaluating 1-year persistence with oral bisphosphonates
- Factors related with osteoporosis treatment in postmenopausal women
- Impact of Osteoporosis on the Risk of Dementia in Almost 60,000 Patients Followed in General Practices in Germany
- A systematic review of factors affecting medication adherence among patients with osteoporosis
- Osteoporotic fractures and subsequent fractures: imminent fracture risk from an analysis of German real-world claims data
- Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteo
- Stimulant Medication Associated With Decreased Bone Mass in Children
- Fracture liaison service
Related papers
- Types Research of Discontinuation of a Crime
- Current and future applications of SPECT in clinical psychiatry.
- [Discontinuation of chronic treatment with lithium salts].
- Contraceptive discontinuation and switching in urban Istanbul region in Turkey
- Management of antiepileptic drugs following epilepsy surgery: a meta-analysis.
- Ezogabine skin discoloration is reversible after discontinuation
- Contraceptive discontinuation due to method dissatisfaction in the United States
- Pattern of discontinuation of intrauterine copper T 380a at the University College Hospital, Ibadan: a ten-year review.